DAFNA Capital Management’s BioNTech BNTX Stock Holding History

DAFNA Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$651K	Hold	7,000	–	–	0.12%	70
2026 Q1	$622K	Hold	7,000	–	–	0.14%	73
2025 Q4	$666K	Hold	7,000	–	–	0.15%	66
2025 Q3	$690K	Hold	7,000	–	–	0.17%	64
2025 Q2	$745K	Sell	7,000 -3,500	-33%	-$354K	0.21%	62
2025 Q1	$956K	Buy	10,500 +2,000	+24%	+$224K	0.27%	60
2024 Q4	$969K	Hold	8,500	–	–	0.25%	57
2024 Q3	$1.01M	Buy	+8,500	New	+$781K	0.24%	63
2024 Q2	–	Sell	-17,000	Closed	-$1.57M	–	84
2024 Q1	$1.57M	Buy	+17,000	New	+$1.63M	0.36%	51

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

DAFNA Capital Management's BNTX Position: Q2 2026 in Review

DAFNA Capital Management held its BioNTech (BNTX) position steady in Q2 2026 at 7,000 shares worth $651K. The position accounts for 0.12% of the portfolio, ranked #70.

DAFNA Capital Management first reported a position in BNTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.57M in Q1 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

DAFNA Capital Management held 7,000 shares of BioNTech worth $651K as of Q2 2026.
DAFNA Capital Management left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.12% of DAFNA Capital Management's portfolio in Q2 2026, its #70 holding.
DAFNA Capital Management first reported a position in BioNTech in Q1 2024 and has held it in 9 quarters since.
DAFNA Capital Management's BioNTech position peaked at $1.57M in Q1 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.